Hartung, Hans-Peter

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 6,969

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 5,017

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 2,021

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 1,905

Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

Chun, J., & Hartung, H.-P. (2010) · Clinical Neuropharmacology

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 796

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Cree, B. A. C., Bennett, J. L., Kim, H. J., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., Fujihara, K., Paul, F., Cutter, G. R., Marignier, R., et al. (2019) · The Lancet

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 756

MRI white matter hyperintensities: Three-year follow-up of the Austrian Stroke Prevention Study

Schmidt, R., Fazekas, F., Kapeller, P., Schmidt, H., & Hartung, H.-P. (1999) · Neurology

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 342

Macrophages prevent hemorrhagic infarct transformation in murine stroke models

Gliem, M., Mausberg, A. K., Lee, J., Simiantonakis, I., van Rooijen, N., Hartung, H., & Jander, S. (2012) · Annals of Neurology

Neuroinflammation and Neurodegeneration MechanismsAcute Ischemic Stroke Management

Cited by 284

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings

Coles, A. J., Cohen, J. A., Fox, E. J., Giovannoni, G., Hartung, H.-P., Havrdova, E., Schippling, S., Selmaj, K. W., Traboulsee, A., Compston, D. A. S., et al. (2017) · Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 277

Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy

Havrdova, E., Arnold, D. L., Cohen, J. A., Hartung, H.-P., Fox, E. J., Giovannoni, G., Schippling, S., Selmaj, K. W., Traboulsee, A., Compston, D. A. S., et al. (2017) · Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 221

Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation

Kremer, D., Schichel, T., Förster, M., Tzekova, N., Bernard, C., van der Valk, P., van Horssen, J., Hartung, H., Perron, H., & Küry, P. (2013) · Annals of Neurology

Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanisms

Cited by 178

Remyelinating strategies for the treatment of multiple sclerosis

Stangel, M., & Hartung, H.-P. (2002) · Progress in Neurobiology

Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanisms

Cited by 126

Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography

Ringelstein, M., Albrecht, P., Kleffner, I., Bühn, B., Harmel, J., Müller, A.-K., Finis, D., Guthoff, R., Bergholz, R., Duning, T., et al. (2015) · Neurology

Ocular Diseases and Behçet’s SyndromeRetinal and Optic Conditions

Cited by 65

The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors

Vermersch, P., Airas, L., Berger, T., Deisenhammer, F., Grigoriadis, N., Hartung, H.-P., Magyari, M., Popescu, V., Pozzilli, C., Pugliatti, M., et al. (2025) · Frontiers in Immunology

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 21